Related Experiment Video
Updated: Jul 17, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
An informatics-supported intervention improves diabetes control in a primary care setting
David C Ziemer1, Circe Tsui, Jane Caudle
1Emory University School of Medicine, USA.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|January 24, 2007
Summary
Healthcare providers can improve diabetes management by using decision support tools. These systems help intensify treatment when needed, leading to better glucose control for patients with diabetes.
Area of Science:
- Diabetes management
- Clinical decision support
- Healthcare quality improvement
Background:
- Despite evidence of improved outcomes with proper diabetes management, glycemic control is declining.
- Clinical inertia, the failure of healthcare providers to intensify diabetes therapy when indicated, contributes to worsening glucose control.
Purpose of the Study:
- To evaluate the effectiveness of an intervention designed to overcome clinical inertia in diabetes management.
- To improve provider adherence to treatment intensification guidelines and enhance patient glycemic control.
Main Methods:
- Implementation of a multi-faceted intervention including patient-specific decision support reminders for providers.
- Provision of computer-generated, provider-specific performance feedback to address clinical inertia.
- Monitoring changes in treatment intensification frequency and glycemic control metrics.
Main Results:
- The intervention significantly increased the frequency with which providers intensified diabetes therapy.
- Improved provider adherence to treatment intensification protocols was observed.
- Patients receiving care from providers using the intervention demonstrated improved glycemic control.
Conclusions:
- A combined approach of decision support reminders and provider feedback effectively reduces clinical inertia in diabetes care.
- This intervention strategy improves therapeutic intensification and leads to better glycemic outcomes for patients with diabetes.
- The findings highlight the potential of health information technology to enhance chronic disease management and improve patient health.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...